Stay updated on Study CB-839 + Paclitaxel in TNBC: Clinical Trial
Sign up to get notified when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.

Latest updates to the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page
- CheckyesterdayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check23 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check52 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has undergone significant updates regarding the clinical study of CB-839 in combination with paclitaxel for advanced triple negative breast cancer, including changes to the study's description and participant criteria.SummaryDifference14%
- Check73 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Study CB-839 + Paclitaxel in TNBC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.